Search research articles
Contact Us
Filters
Showing results (111-120 of 375) with videos related to
Page
of 38
Sort By:
Practical Radiation Oncology
|
May 25, 2023
Practical Steps to Mitigate Cybersecurity Attacks on Radiation Oncology Practices
James B Yu, Adam P Dicker, Nataniel H Lester-Coll, et al.
Expert Review of Anticancer Therapy
|
October 16, 2013
Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
Nicholas G Zaorsky, Laura A Doyle, Mark D Hurwitz, et al.
British Journal of Cancer
|
February 22, 2014
Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
M M Wattenberg, A R Kwilas, S R Gameiro, et al.
Journal of Neuro-Oncology
|
April 26, 2011
Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic
Phyllis R Wachsberger, Richard Yaacov Lawrence, Yi Liu, et al.
FEBS Letters
|
January 9, 1995
Calcium-dependent translocation of sorcin to membranes: functional relevance in contractile tissue
M B Meyers, C Zamparelli, D Verzili, et al.
Journal of the American College of Radiology : JACR
|
December 19, 2012
Predictors of radiation oncology resident research productivity
Jordan M Gutovich, Robert B Den, Maria Werner-Wasik, et al.
Expert Review of Medical Devices
|
December 26, 2014
Is robotic arm stereotactic body radiation therapy “virtual high dose ratebrachytherapy” for prostate cancer? An analysis of comparative effectiveness using published data [corrected]
Nicholas George Zaorsky, Mark D Hurwitz, Adam P Dicker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model
Borbala Daroczi, Gabor Kari, Mary Frances McAleer, et al.
Frontiers in Oncology
|
February 6, 2013
Epidermal growth factor receptor mutation status and rad51 determine the response of glioblastoma to multimodality therapy with cetuximab, temozolomide, and radiation
Phyllis Rachelle Wachsberger, Richard Yaacov Lawrence, Yi Liu, et al.
Expert Review of Medical Devices
|
November 8, 2013
Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
Nicholas G Zaorsky, Robert B Den, Laura A Doyle, et al.
Page
of 38
Search research articles
Search
Showing results (111-120 of 375) with videos related to
Sort By:
Page
of 38
Practical Radiation Oncology
|
May 25, 2023
Practical Steps to Mitigate Cybersecurity Attacks on Radiation Oncology Practices
James B Yu, Adam P Dicker, Nataniel H Lester-Coll, et al.
Expert Review of Anticancer Therapy
|
October 16, 2013
Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
Nicholas G Zaorsky, Laura A Doyle, Mark D Hurwitz, et al.
British Journal of Cancer
|
February 22, 2014
Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
M M Wattenberg, A R Kwilas, S R Gameiro, et al.
Journal of Neuro-Oncology
|
April 26, 2011
Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic
Phyllis R Wachsberger, Richard Yaacov Lawrence, Yi Liu, et al.
FEBS Letters
|
January 9, 1995
Calcium-dependent translocation of sorcin to membranes: functional relevance in contractile tissue
M B Meyers, C Zamparelli, D Verzili, et al.
Journal of the American College of Radiology : JACR
|
December 19, 2012
Predictors of radiation oncology resident research productivity
Jordan M Gutovich, Robert B Den, Maria Werner-Wasik, et al.
Expert Review of Medical Devices
|
December 26, 2014
Is robotic arm stereotactic body radiation therapy “virtual high dose ratebrachytherapy” for prostate cancer? An analysis of comparative effectiveness using published data [corrected]
Nicholas George Zaorsky, Mark D Hurwitz, Adam P Dicker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model
Borbala Daroczi, Gabor Kari, Mary Frances McAleer, et al.
Frontiers in Oncology
|
February 6, 2013
Epidermal growth factor receptor mutation status and rad51 determine the response of glioblastoma to multimodality therapy with cetuximab, temozolomide, and radiation
Phyllis Rachelle Wachsberger, Richard Yaacov Lawrence, Yi Liu, et al.
Expert Review of Medical Devices
|
November 8, 2013
Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
Nicholas G Zaorsky, Robert B Den, Laura A Doyle, et al.
Page
of 38